Keep Holding Twist Bioscience (TWST)
I’ve been saying that our “Imperium” stock, Twist Bioscience Corp. (Nasdaq: TWST), has the potential to be a $1,000 stock, and that hasn’t changed.
Read MoreI’ve been saying that our “Imperium” stock, Twist Bioscience Corp. (Nasdaq: TWST), has the potential to be a $1,000 stock, and that hasn’t changed.
Read MorePosted by paul kranowitz | May 5, 2021
This week, I discuss how the Federal Reserve has given us trillions of reasons to focus on gold — and I do a deep dive on our gold miner Agnico Eagle (NYSE: AEM) after its latest earnings announcement. I also explain why chief investment strategist Adam O’Dell and I are still bullish on our competitive gaming play, Turtle Beach Corp. (Nasdaq: HEAR) — including the latest news about an activist investor.
Read MorePosted by paul kranowitz | Apr 28, 2021
This week, I share an update following earnings from one of our industrial stocks. Of course, I already liked Insteel Industries Inc. (NYSE: IIIN) — but I think that you’ll agree that it’s even more of a no-brainer buy today!
Read MoreI share big news from our genomics play, Twist Bioscience (TWST), and our Indian tech consultant, Wipro Ltd. (NYSE: WIT). I advise to a new buy-up-to price for WIT.
Read MoreIn recent months, we’ve highlighted trends ranging from genomics (DNA technology) to competitive video gaming to gritty, old infrastructure construction.
Read MoreIn his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below